c.moreau
Submits third-party assay reports on material purchased directly. Based in Ghent.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.82%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043650 | BPC-157 | BCH | BCH-2603-L7657 | Janoshik | 2026-Q3 | 98.15 | 4.81 | 107.3 | Buyer-sourced | 0 | PASS |
| AX-2026-041863 | CJC-1295 with DAC | JEEP | JEEP-2509-P4217 | VendorInvestigate | 2025-Q4 | 98.82 | 3.72 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018893 | TB-500 | FGP | FGP-2508-S9736 | Janoshik | 2025-Q4 | 99.86 | 4.01 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019473 | Semaglutide | Homopeptide | HOMO-2505-V1097 | Medutest | 2025-Q3 | 98.74 | 6.50 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019864 | Semaglutide | SWB | SWB-2504-Y5209 | Janoshik | 2025-Q3 | 99.44 | 3.00 | — | Supplier-supplied | 0 | PASS |
| AX-2025-021209 | TB-500 | WXT | WXT-2506-K5706 | Janoshik | 2025-Q3 | 97.86 | 6.88 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-020151 | Tirzepatide | ERP | ERP-2502-T8835 | Medutest | 2025-Q1 | 98.44 | 3.37 | — | Buyer-sourced | 1 | FAIL |
| AX-2024-005080 | BPC-157 | GGPeps | GGPE-2406-E2742 | Nordanalyt | 2024-Q3 | 99.93 | 3.07 | — | Buyer-sourced | 1 | FAIL |
| AX-2024-004816 | GHRP-6 | Homopeptide | HOMO-2407-T1480 | Janoshik | 2024-Q3 | 99.93 | 6.71 | — | Buyer-sourced | 0 | PASS |